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Bluetongue virus (BTV) core-like particles (CLPs) are formed in the cytoplasm of insect cells when only two major proteins
(VP3 and VP7) of the BTV core are expressed by baculovirus vectors (T. J. French and P. Roy, 1990, J. Virol. 64, 1530–
1536). We have recently reported that five small internal deletion mutants of VP3 form CLPs when provided with unmodified
VP7 protein (D1–5; S. Tanaka and P. Roy, 1994, J. Virol. 68, 2795–2802). To investigate whether foreign sequences can be
inserted into VP3 and to determine their effect on CLP formation, three of these internal regions (D1, D2, and D5), as well
as the carboxy terminus, were modified to create unique restriction enzyme sites, thereby replacing VP3 coding regions
with shorter synthetic sequences. Each modified VP3 gene was used to generate baculovirus expression vectors (D1I, D2I,
D5I, and VP3C, respectively). Other than the D5I mutant, the mutants formed CLPs when expressed in the presence of VP7.
Subsequently, T7 tag epitopes were inserted into the D1I, D2I, and VP3C restriction sites and recombinant baculoviruses
were generated to express chimeric VP3 proteins (VP3D1IT, VP3D2IT, and VP3CT). Each chimeric protein retained the ability
to form CLPs when VP7 protein was provided. In another construction an immunogenic sequence representing a bovine
leukemia virus (BLV) glycoprotein peptide was incorporated into the carboxy terminus of VP3 and the derived CLPs were
used to raise antibodies that reacted with the BLV antigen. The results suggest that the VP3 molecule can accommodate
foreign sequences at certain sites without perturbing their ability to form CLPs with VP7. q 1995 Academic Press, Inc.
INTRODUCTION will allow other potential insertion sites in VP7 to be
investigated (Grimes et al., 1995).
Bluetongue virus (BTV), a member of the Reoviridae, We recently reported that deletions of selected internal
has a double-shelled capsid structure consisting of regions within VP3 do not prohibit CLP formation al-
seven proteins (VP1–7). The VP3 protein is a major com- though some of the derived particles were less stable
ponent of the BTV core and forms a subcore together than those made from authentic VP3 and VP7 (Tanaka
with the three minor structural proteins (VP1, VP4, VP6) and Roy, 1994). The present investigation was under-
and the 10 double-stranded RNA (dsRNA) segments of taken to determine whether certain internal regions of
the genome. VP3 forms a scaffold for the deposition of VP3, as well as the carboxy terminus, would tolerate
VP7 protein, the surface protein of the core. The outer substitution/extension and still retain the ability to form
layers of the virus consist of VP2 and VP5. We have CLPs. Mutants of VP3 cDNA were generated in which
previously coexpressed BTV VP3 and VP7 proteins in nucleotide sequences were replaced to provide unique
insect cells using baculovirus vectors and demonstrated restriction sites to insert foreign epitopes. All but one of
that core-like particles (CLPs) can be assembled which the modified VP3 species interacted with VP7 to form
structurally resemble virus-derived cores except for the CLPs. Data are presented which indicate that foreign
absence of the dsRNA genome and the minor proteins epitopes can be introduced into these sites and that
(French and Roy, 1990). the modified VP3 molecules assembled into CLPs in the
It has been shown that following the addition of extra presence of VP7. In addition, amino acid sequences were
residues to the amino terminus of the BTV VP7 protein added to the carboxy terminus of VP3 and also incorpo-
(Le Blois and Roy, 1993; Belyaev and Roy, 1992) the ex- rated into CLPs. The results extend the previous informa-
pressed products can interact with VP3 to form chimeric tion on the preparation of chimeric CLPs and the require-
CLPs in insect cells. In some cases the modified VP7 ments for BTV particle formation.
molecule required the presence of unmodified VP7 to
form stable CLPs. Recently, the three-dimensional crys- METHODS
tallographic structure of VP7 has been obtained which
Viruses and cells
AcNPV and recombinant baculoviruses were propa-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 44-1865-59962. gated in Spodoptera frugiperda (Sf) cells at 287 as de-
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FIG. 1. Diagrams of the identified amino acids deleted from the VP3 D1, D2, and D5 regions and the flanking amino acids, restriction sites, and
encoded amino acids in the transfer vectors pAcYM1.17.3D1I, pAcYM1.17.3D2I, pAcYM1.17.3D5I, and pAcYM1.17.3C. Each inserted restriction site
is represented by a white square with the enzyme name. Natural unique enzyme sites in the selected regions are unboxed (see Table 1 and text).
scribed by Brown and Faulkner (1977) using TC100 me- nucleotides 241 – 246 of the VP3 gene). The large DNA
fragment containing the remaining VP3 gene was pu-dium (GIBCO International) containing 10% (v/v) fetal calf
serum. rified by agarose gel electrophoresis. A mutant DNA
fragment including a restriction enzyme cassette at
DNA manipulations and construction of transfer the D1 region was synthesized by PCR using pA-
vectors cYM1.17.3 and the forward- and reverse-sense prim-
ers given in Table 1. The DNA sequence correspond-Plasmid DNA manipulations were undertaken essen-
ing to amino acid residues immediately upstream oftially as summarized by Sambrook et al. (1989). Restric-
the cassette was amplified by PCR using the forwardtion enzymes, T4 DNA ligase, and calf intestinal alkaline
primer 1 and back primer 2 (see Table 1). The re-phosphatase were purchased from Amersham Interna-
sulting fragment contained NaeI and SacI flankingtional plc.
sites. The sequence corresponding to amino acids
immediately downstream of the cassette was ampli-Polymerase chain reactions
fied using forward primer 3 and back primer 4 (Table
The polymerase chain reactions (PCR) were performed 1). The resulting fragment contained SacI and PstI
using a Hybaid thermal reactor. Plasmid DNA and oligo- flanking sites. The upstream fragment was digested
nucleotide primers were initially denatured at 947 for 30 with NaeI and SacI and the downstream fragment was
sec and annealed for 20 sec, and DNA was synthesized digested with SacI and PstI. After purification, these
at 727 for 1 min. The products were then subjected to 30 fragments were ligated with the large fragment ex-
rounds of further amplification. cised from pAcYM1.17.3 to provide the mutant pA-
cYM1.17.3D1I (Fig. 1). For the mutant vector pA-
Construction of insertion cassettes in BTV L3 cDNA cYM1.17.3D2I, the plasmid pAcYM1.17.3 was di-
gested with BglII (residues 1042 – 1047 of the VP3A plasmid containing the BTV-17 L3 cDNA (pA-
gene) and NruI (residues 1345 – 1350) and ligated tocYM1.17.3; Marshall and Roy, 1990) was employed.
the PCR product produced using forward primer 5 andUsing PCR, mutant L3 sequences were constructed
reverse primer 6 (Table 1) also digested with Bg1IIto provide unique internal restriction sites at specific
and NruI, to generate pAcYM1.17.3D2I. For pA-locations (see Fig. 1). Small fragments encompassing
cYM1.17.3D5I, the forward primer 7 and reversethe target sites were excised and replaced with mu-
primer 8 (Table 1) were employed with pAcYM1.17.3tant sequences synthesized by PCR (see Tanaka and
to make a PCR product. This fragment was digestedRoy, 1994). The mutant vector pAcBTV17.3D1I was
with NruI and DraIII and ligated to NruI- and DraIII-constructed as follows: pAcYM1.17.3 was digested
cut pAcYM1.17.3 to generate the recombinant transferwith NaeI (a unique site in the plasmid upstream of
the VP3 coding sequence) and PstI (corresponding to vector pAcYM1.17.3D5I. The unique DraIII site in pA-
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cYM1.17.3C was digested with XbaI and StuI. In each
case the large fragment was purified by gel electrophore-
sis. The T7 tag DNA (see Table 2) with a 5* XbaI-compati-
ble end and blunt other end was ligated with each of
these fragments. The derived plasmids were designated
pAcYM1.17.3D1IT, pAcYM1.17.3D2IT, and pAcYM1.17.3CT
and used to express mutant VP3 proteins. A bovine leu-
kemia virus glycoprotein 51 (BLV gp51) sequence (aa
155–167) with a 5* XbaI-compatible and blunt other end
was ligated with XbaI-, StuI-cut pAcYM1.17.3C. A 44-
amino-acid sequence corresponding to Clostridium diffi-
cile toxin A (PCG-4; aa 2098–2141) flanked with SpeI and
SmaI sites (see Table 2) was cloned into pAcYM1.17.3D2I
previously digested with XbaI and SmaI. Each recombi-
nant transfer vector was used to generate recombinant
viruses.
Transfection and selection of recombinant viruses
Sf cells were transfected with a mixture of plasmid
DNA (1 mg) and linearized BacPAK6 DNA (50 ng) as
described by Kitts and Possee (1993). Recombinant bac-
uloviruses were selected after staining with X-gal (5-
bromo-4-chloro-3-indolyl-D-galactopyranoside) to identify
nonrecombinant viruses, and selected recombinantsFIG. 2. Diagram of the construction of the plasmid transfer vector
were plaque-purified as described previously (Kitts et al.,pAcYM1.17.3C. The transfer vector pAcYM1.17.3 was digested with
BglI, and three differently sized fragments were purified by agarose 1990). After two further plaque passages virus stocks
gel electrophoresis. The middle-sized fragment was ligated with mutant were generated.
oligonucleotides 3B and 3C (Table 1) and then with the other two
fragments. Each BglI site has a different sequence in pAcYM1.17.3.
SDS–PAGE analysisTherefore pAcYM1.17.3C was reconstructed by ligation of all three
fragments. This plasmid provides a XbaI–StuI cassette to insert se-
Protein dissociation buffer [10% (v/v) b-mercaptoetha-quences.
nol, 10% (w/v) sodium dodecyl sulfate (SDS), 25% (w/v)
glycerol, 10 mM Tris–HCl (pH 6.8), 0.02% (w/v) bromo-
cYM1.17.3 is located at BTV residues 1632 – 1640. The phenol blue] was added to each sample, and mixtures
mutant sequences in the derived recombinant trans- were heated to 1007 for 5 min. Proteins were resolved
fer vectors were confirmed by sequencing (Sanger et by SDS–polyacrylamide gel electrophoresis (PAGE) and
al., 1977). stained with Kenacid blue (Overton et al., 1987).
Construction of pAcYM1.17.3C for VP3 carboxy
Immunoblotting analysisextension mutants
Proteins resolved by SDS–PAGE were electroblottedThe construction of recombinant plasmid pA-
to an Immobilon membrane (Millipore International). ThecYM1.17.3C is summarized in Fig. 2. The transfer vector,
membrane was incubated for 1 hr at 377 in blockingpAcYM1.17.3, was digested with BglI and the three differ-
buffer [5% (w/v) skimmed milk, 0.05% (w/v) Tween 20ently sized fragments were each purified. The medium-
in phosphate-buffered saline (PBS)]. Anti-T7 tag epitopesized fragment was ligated with mutant oligonucleotides
monoclonal antibody [Novagen; 1:3000 dilution in a3B and 3C (Table 1) and ligated with the other two frag-
washing buffer consisting of 0.05% (w/v) Tween 20 inments. Each BglI site [GCC(N)4NGGC] of pAcYMI.17.3
PBS] was added and the membrane was incubated over-has a different (N)4N sequence, hence the plasmid was
night at room temperature. After four 8-min washes inreconstructed in the required order by ligation of the
washing buffer, the bound antibody was detected by per-BglI cut fragments. The resulting plasmid, pAcYM1.17.3C,
oxidase-conjugated protein A (Sigma Chemical Co., St.contains the indicated XbaI–StuI cassette.
Louis, MO). The ECL system (Gibco BRL International)
was used to detect attached conjugate.Construction of transfer vectors for substitution or
extension with sequences representing foreign
Immunoprecipitation analysisepitopes
The transfer vectors pAcYM1.17.3D1I and pA- [35S]-Labeled proteins in RIPA buffer [160 mM NaCl, 5
mM MgCl2 , 10 mM Tris–HCI (pH 7.4), 0.5% (v/v) NonidetcYM1.17.3D2I were digested with XbaI and SmaI. pA-
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TABLE 2
T7 epitope
(S) (S) M A S M T G G Q Q M G R (G or P)
CT AGT ATG GCT TCT ATG ACT GGT GGT CAA CAA ATG GGG CGT
A TAC CGA AGA TAC TGA CCA CCA GTT GTT TAC CCC GCA
44-amino-acid sequence from Clostridium difficile toxin A
(S) (S) A T G W Q T I D G K K Y Y F N T N T
CT AGT GCA ACG GGC TGG CAG AGC ATC GAT GGC AAG AAA TAT TAT TTT AAT ACG AAT ACC
A CGT TGC CCG ACC GTC TGC TAG CTA CCG TTC TTT ATA ATA AAA TTA TGC TTA TGG
A E A A T G W Q T I D G K K Y Y F N T N
GCT GAA GCC GCT ACC GGT TGG CAA ACT ATA GAC GGT AAG AAG TAC TAC TTC AAC ACC AAC
CGA CTT CGG CTA TGG CCA ACC GTT TGA TAT CTG CCA TTC TTC ATG ATG AAG TTG TGG TTG
T A I A S T (P) (G)
ACT GCC ATT GCT AGC ACC CCC
TGA CGG TAA CGA TCG TGG GGG
BLV gp51 epitope
(S) (S) N S D W V P S V R S W A L (P)
CT AGT AAC AGT GAC TGG GTT CCC TCT GTC AGA TCA TGG GCC CTG
A TTG TCA CTG ACC CAA GGG AGA CAG TCT AGT ACC CGG GAC
Note. The sequences employed to modify BTV L3 (VP3) cDNA and the antigens they encode are provided. The 5* overhangs derived from SpeI
digestions allow the DNA fragments to anneal to XbaI-cut DNA and, with the first T of the XbaI site, provided two extra amino acids, (S) and (S).
The blunt ends allow the DNA to be ligated to SmaI-cut DNA to provide an extra glycine (G) or, for Stu I-cut DNA, an extra proline (P).
P-40] recovered from Sf cells previously infected with a concomitant deletion of natural sequences and replace-
ment with shorter peptides (see Fig. 1) affected the ex-recombinant baculovirus were incubated with anti-T7 tag
epitope monoclonal antibody (1:100 dilution in PBS on pression of VP3, each transfer vector was used to gener-
ate a recombinant baculovirus as described under Meth-ice for 1 hr). Protein A–Sepharose CL-4B beads (in RIPA
buffer) were added and the incubation was continued ods. The recombinants were replaqued three times and
the recombinant viruses (designated AcBTV17.3D1I, AcB-for a further 1.5 hr on ice with regular mixing, before
centrifugation and thorough washing of the beads. The TV17.3D2I, AcBTV17.3D5I, and AcBTV17.3C) were se-
lected for further characterization. Sf cells were infectedprecipitated proteins were removed by boiling for 5 min
in dissociation buffer, resolved on a 10% SDS–PAGE gel, with each recombinant virus and the protein products
were analyzed by SDS–PAGE (Fig. 3). Each recombinantand located by autoradiography.
Purification of CLPs
Sf cells were infected at a m.o.i. of 5 PFU per cell with
AcBTV-10.7 and the indicated recombinant VP3 baculovi-
ruses. Cells were harvested 48 hr postinfection, washed
with PBS, and lysed at 47 in TNN buffer [50 mM Tris –
HCl (pH 8.0), 150 mM NaCl, 0.5% (w/v) NP-40]. Particles
were purified as described previously (French and Roy,
1990) by banding on an 11-ml discontinuous sucrose
gradient [30–66% (w/v) in 0.2 M Tris–HCl, pH 8.0] after
centrifugation at 85,000 g for 2.5 hr. The particles were
analyzed by SDS–PAGE and electron microscopy.
RESULTS
FIG. 3. Expression of the VP3 mutants in insect cells. Sf cells were
infected at a m.o.i. of 5 PFU per cell with recombinant baculovirusesThe modification of VP3 at internal sites and the
expressing VP3 mutants (D1I, D2I, D5I, or VP3C) or with a recombinantcarboxy terminus and ability of the modified VP3 to
baculovirus expressing unmodified VP3 (Inumaru et al., 1987). Cells
form CLPs with unmodified VP7 were harvested 3 days postinfection. Uninfected (Sf cell lysate) cells
and Sf cells infected with BacPAK6 expressing b-galactosidase (Bac-The transfer vectors pAcYM1.17.3D1I, pAcYM1.17.3D-
PAK6) served as a controls. Proteins recovered from the cell extracts
2I, pAcYM1.17.3D5I, and pAcYM1.17.3C were con- were separated by SDS–PAGE and stained with Kenacid blue (see
structed as described under Methods. To investigate Methods). The sizes of molecular weight markers are indicated in kilo-
daltons. The positions of VP3 and b-galactosidase (b-gal) are indicated.whether the insertion of restriction enzyme sites and the
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virus synthesized band with a migration pattern similar
to unmodified VP3 protein expressed by AcBTV17.3 (Inu-
maru et al., 1987; Marshall and Roy, 1990). The mutant
VP3 proteins were designated D1I, or D2I, or D5I, or VP3C
(Fig. 3). Immunoblotting using BTV-10 antisera confirmed
that the bands were VP3 (data not shown).
To investigate whether the expressed VP3D1I, VP3D2I,
VP3D5I, and VP3C proteins interacted with unmodified
VP7 protein and formed CLPs, insect cells were co-in-
fected with recombinant baculoviruses in the presence
of AcBTV10.7 BTV-10 VP7 protein (Oldfield et al., 1990).
Infected cells were lysed and supernatants were re-
solved by sucrose gradient centrifugation as described
under Methods. CLPs were detected by the formation of
opalescent bands of particles in the gradient. Only one
mutant, VP3D5I, did not form a band of CLPs (French and
Roy, 1990). Samples collected from the same position of
FIG. 5. Expression of VP3 mutants with a T7 tag epitope. Sf cellseach sucrose gradient were analyzed by SDS–PAGE and
were infected at m.o.i. of 5 PFU per cell with recombinant baculoviruses
by electron microscopy. As shown in Fig. 4, the mutants expressing a mutant VP3 (D1IT, D2IT, or VP3CT) or unmodified VP3
D1I, D2I, and VP3C formed CLPs in the presence of VP7. (BTV.VP3). The cells were harvested 3 days postinfection. Uninfected
cells (Sf cell lysate) or Sf cells infected with BacPAK6 expressing b-Although the expression levels of chimeric VP3 of the
galactosidase (b-gal) served as controls (BacPAK6). Proteins recoveredrecombinants were variable, the molar ratio of chimeric
from the cell extracts were separated by SDS–PAGE and stained withVP3 to VP7 in each preparation was similar to that of
Kenacid blue. (Top) The protein samples analyzed by SDS–PAGE. (Bot-
authentic CLPs. No CLP proteins were detected with D5I. tom) The samples analyzed by Western blotting using an anti-T7 mono-
The presence of CLPs was also confirmed by electron clonal antibody. The positions of VP3 and b-gal are indicated.
microscopy (data not shown).
nus), a number of different foreign epitopes were se-Synthesis of chimeric VP3–T7 molecules by
lected. Initially, a short peptide fragment (Table 2,recombinant baculoviruses
MASMTGGQQMGR) representing the T7 major capsid
To create chimeric VP3 molecules either by substi- protein was employed (Rosenberg et al., 1987). The
tution (internal sites) or by extension (carboxy termi- peptide is the natural amino terminus of the T7 protein
and can be detected using a commercially available
monoclonal antibody (Tsai et al., 1992). To insert the
T7 epitope into VP3, three of the modified plasmids,
pAcYM1.17.3D1IT, pAcYM1.17.3D2IT, and pAcYM1.17.3CT,
were utilized as described under Methods and three
recombinant viruses were generated (D1IT, D2IT, and
VP3CT, respectively). Synthesis of mutant VP3 pro-
teins carrying the T7 tag was examined by SDS –
PAGE and Kenacid staining of the infected cell ly-
sates (Fig. 5). To determine whether each expressed
molecule was a chimeric protein, Western immu-
noblotting analysis was carried out using an available
monoclonal antibody. Each chimeric protein reacted
with the T7 antibody, indicating that the mutant
VP3 molecules possessed the T7 epitopes (Fig. 5,
bottom).
FIG. 4. Protein analysis of purified CLPs containing modified VP3.
Sf cells were co-infected at m.o.i. of 5 PFU of each virus per cell using Chimeric VP3 proteins carrying foreign epitopes can
the baculoviruses expressing mutant BTV VP3 proteins (D1I, D2I, D5I, be assembled into core-like particles
or VP3C) and a baculovirus expressing BTV-10 VP7. As a control, cells
were similarly co-infected with recombinants expressing VP3 and VP7 To test whether chimeric VP3 protein with foreign epi-
(BTV-CLP) protein. Cells were harvested 2 days postinfection and lysed topes could form CLPs in the presence of VP7 protein,
with the nonionic detergent NP-40. The expressed particles were puri- each recombinant virus was used to co-infect the Sf cells
fied from cell lysates on discontinuous sucrose gradients. Protein sam-
together with AcBTV-10. VP7 (Oldfield et al., 1990), andples were resolved by SDS–PAGE and stained with Kenacid blue. No
the synthesis of CLPs was analyzed by sucrose gradientCLPs were obtained from the D5I co-infection. The positions of VP3
and VP7 are indicated. centrifugation as described above. In each case, a dis-
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FIG. 6. Protein analysis and electron micrographs of sucrose gradient-purified CLPs containing VP3 with a T7 epitope. Sf cells were co-infected
at m.o.i. of 5 PFU per cell with recombinant baculoviruses expressing mutant VP3 (D1IT, D2IT, or VP3CT) and a recombinant baculovirus expressing
BTV-10 VP7. As a control, cells were co-infected at the same m.o.i. with recombinants that express BTV-17 VP3 and BTV-10 VP7 proteins (BTV-
CLP). Cells were harvested 2 days postinfection and lysed with the nonionic detergent NP-40 and the expressed particles were purified on
discontinuous sucrose gradients. (A) The protein samples were resolved by SDS–PAGE and stained with Kenacid blue. (B) Electron micrographs
of CLPs from VP3D1IT (a) and VP3CT (b). In both cases the particles appeared to lack some of the surface VP7 trimers.
tinct band was visualized. Each band was collected and Introduction of a large peptide fragment perturbs CLP
formationanalyzed by SDS–PAGE followed by staining (Fig. 6A).
Particles were also examined by electron microscopy
To determine whether a large peptide could be intro-(Fig. 6B). Both VP7 and VP3 were identified in the CLP
duced into a internal site of VP3 and permit CLP forma-preparation. The one-step purification of CLPs by su-
tion, the 44-amino-acid so-called repeating unit of C.crose gradient purification (French and Roy, 1990) pro-
difficile toxin A together with 4 additional flankingvided some background bands of cellular materials.
amino acids (Table 2) was inserted into the D2 regionWhen subjected to a further round of CsCl gradient purifi-
(Dove et al., 1990). A recombinant transfer vector wascation, very few particles were recovered. These obser-
generated and utilized to isolate a recombinant bacu-vations suggested that CLPs formed from these mutant
lovirus expressing the chimeric protein. As shown inVP3 species were less stable than those made from
authentic proteins. Fig. 7, the expressed chimeric protein was detected
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dimers of disk-shaped VP3 molecules. The 12 corners of
each dimer are in close contact with 12 VP7 trimers at
the twofold axes. In the absence of VP7 trimers, subcores
rapidly dissociate, indicating that the interactions be-
tween VP7 and VP3 are essential for the stability of the
BTV core. Previous studies have demonstrated that a
number of hydrophobic stretches within the VP3 mole-
cule are not required for VP3–VP7 interactions (Tanaka
and Roy, 1994). The present studies were undertaken to
determine whether these regions would tolerate substitu-
tion or extension without affecting the formation of CLPs.
Chimeric VP3 molecules were generated. Of the five re-
gions (D1–D3, D5, and D6; Tanaka and Roy, 1994), we
selected three regions, D1, D2, and D5, for analysis (Fig.FIG. 7. Protein analysis by PAGE and Western immunoblotting of the
VP3 D2I mutant containing the Clostridium difficile toxin A fragment. 1). Two regions, D2 and D5, are located in the middle of
Sf cells were infected with the recombinant baculovirus at a m.o.i. of the VP3 molecule. D1 is located near the amino terminus.
5 PFU per cell, harvested 2 days postinfection and lysed with the Previous studies indicated that deletion in D6 region had
nonionic detergent NP-40. The protein samples were resolved by SDS–
some effect on the stability of assembled CLPs (TanakaPAGE and either stained with Kenacid blue (lane 1) or probed with a
and Roy, 1994). To explore the usefulness of insertion atmonoclonal antibody to the toxin (Dove et al., 1990) (lane 2). The posi-
tion of VP3 is indicated. the carboxy terminus of VP3, we constructed pA-
cYM1.17.3C (Fig. 2).
The replacement at the D5 region (D5I, 4 amino acidsby staining the gel and recognized by an available
in lieu of 13 amino acids, see Fig. 1) did not form CLPs,antibody. Attempts to generate CLPs with this virus in
although the deletion mutant (D5) formed stable CLPsthe presence of authentic VP7 protein were not suc-
(Tanaka and Roy, 1994). The data suggest that the D5cessful. The data indicate that although the D2 region
region can tolerate a deletion but not the amino acidcan be modified, insertion of a 44-amino-acid se-
substitutions employed in this study. It is possible thatquence interfered with VP3 – VP7 interactions and the
the particular substitutions at D5 (or the previously stud-assembly of CLPs.
Extension of the carboxy terminus of the VP3
molecule with a BLV gp51 fragment does not prohibit
VP3–VP7 interaction and the formation of CLPs
To determine whether the carboxy terminus of the VP3
molecule can be extended with an immunogenic peptide
and permit CLP formation, a 13-amino-acid peptide de-
rived from the BLV gp51 envelope glycoprotein repre-
senting the binding domain of the protein to cellular re-
ceptors, together with additional flanking amino acids
(Table 2), was ligated into pAcYM1.17.3CT and a recom-
binant baculovirus was generated (Callebaut et al., 1993).
As shown in Fig. 8A, the expressed molecule formed
CLPs when coexpressed with VP7. The recovery of CLPs
was similar to authentic CLPs as confirmed by PAGE
analysis of gradient purified particles. Both anti-BTV anti-
FIG. 8. Protein analysis and electron micrographs of the purified
body and anti-BLV antibody reacted with the VP3 deriva- CLPs obtained using VP3-containing BLV gp51 sequences. Sf cells
tives recovered from purified CLPs. To determine the were co-infected at m.o.i. of 5 PFU per cell with the recombinant bacu-
lovirus expressing the mutant VP3 molecule and a recombinant ex-immunogenic properties of these particles, antisera were
pressing BTV-10 VP7. Cells were harvested 2 days postinfection andraised in mice and tested against BLV as well as the
lysed with the nonionic detergent NP-40. An aliquot of unpurified cellCLPs. As shown in Fig. 8 (lanes 6 and 7), the antibody
lysate was saved for analysis. As a control, uninfected cells were
reacted with BLV-infected cell extracts as well as with treated similarly. The expressed particles were purified on discontinu-
CLPs (predominantly VP7). The data suggest that the ous sucrose gradients. Protein samples were resolved by SDS–PAGE
and stained with Kenacid blue. Lane 1 shows an uninfected cell lysate;carboxy terminus of the BTV VP3 molecule can be utilized
lane 2, an infected cell lysate; lane 3, purified CLPs. In lane 4 is shownto present immunogenic foreign epitopes.
a Western analysis of purified particles probed with anti-BTV antiserum,
and in lane 5, the same sample probed with anti-BLV antiserum. InDISCUSSION
lane 6 is shown SDS–PAGE of a BLV-infected cell lysate, and in lane
The BTV subcore, which serves as scaffold for the 7, the CLPs. The proteins in lanes 6 and 7 were probed with antibody
generated with the CLPs. (B) Electron micrograph of the derived CLPs.deposition of VP7 trimers, is composed of closely bonded
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Brown, M., and Faulkner, P. (1977). A plaque assay for nuclear polyhe-ied D4; Tanaka and Roy, 1994) create structural con-
drosis viruses using a solid overlay. J. Gen. Virol. 36, 361–364.strains in the molecule resulting in aberrant folding of
Callebaut, I., Voneche, V., Mager, A., Fumiere, O., Krchnak, V., Merza,
the protein and abrogation of CLP formation. M., Zavada, J., Mammerickx, M., Burny, A., and Portetelle, D. (1993).
The replacement mutants (D1I and D2I) and T7 inser- Mapping of B-neutralizing and T-helper cell epitopes on the bovine
leukemia virus external glycoprotein gp51. J. Virol. 67, 5321–5327.tion mutants (D1IT and D2IT) were expressed by recom-
Dove, C. H., Wang, S.-Z., Price, S. B., Phelps, C. J., Lyerly, D. M., Wilkins,binant baculoviruses with an efficiency comparable to
T. D., and Johnson, J. L. (1990). Molecular characterization of thethat of unmodified VP3. Although all the mutants formed Clostridium difficile toxin A gene. Infect. Immun. 58, 480–488.
CLPs with VP7, the yields were low, especially with D2IT. French, T. J., and Roy, P. (1990). Synthesis of bluetongue virus (BTV)
core-like particle by a recombinant baculovirus expressing the twoThe D1I replacement mutant involved the exchange of
major structural core proteins of BTV. J. Virol. 64, 1530–1536.10 amino acids (VP3 residues 31–40) with 5 others
Grimes, J., Basak, A., Roy, P., and Stuart, D. (1995). The crystal structure(SRAGP, Fig. 1); the D2I involved the exchange of 6 amino
of bluetongue virus VP7: Implications for virus assembly. Nature 373,
acids (VP3 residues 345–350) with 4 others (SRPG, Fig. 167–170.
1). It is possible that the assembled CLPs were not as Inumaru, S., Ghiasi, H., and Roy, P. (1987). Expression of bluetongue
virus group-specific antigen VP3 in insect cells by baculovirus vector:stable as authentic CLPs and disassembled during purifi-
Its use for the detection of bluetongue virus antibody. J. Gen. Virol.cation. This was confirmed by subsequent CsCl gradient
68, 1627–1635.purification. The ability of the D2 region to accommodate Kitts, P. A., and Possee, R. D. (1993). A method for producing recombi-
added sequences was further investigated by inserting nant baculovirus expression vectors at high frequency. BioTech-
niques 14, 810–817.a 44 / 4-amino-acid peptide. This insertion inhibited the
Kitts, P. A., Ayres, M. D., and Possee, R. D. (1990). Linearization offormation of CLPs.
baculovirus DNA enhances the recovery of recombinant virus expres-In contrast to the internal regions, stable CLPs were
sion vectors. Nucleic Acids Res. 18, 5667–5672.
formed with mutants involving at least a limited extension Le Blois, H., and Roy, P. (1993). A single point mutation in the VP7
of the carboxy terminus of the molecule (a 12-amino-acid major core protein of bluetongue virus prevents the formation of
core-like particles. J. Virol. 67, 353–359.T7 epitope plus 3 extra amino acids or a 13-amino-acid
Lutz-Freyermuth, C., Query, C. C., and Keene, J. D. (1990). QuantitativeBLV gp51 epitope plus 3 extra residues, Table 2). In
determination that one of two potential RNA-binding domains of the
addition, with the BLV insert the CLPs were shown to be A protein component of the U1 small nuclear ribonucleoprotein com-
immunogenic. plex binds with high affinity to stem–loop II of U1 RNA. Proc. Natl.
Acad. Sci. USA 87, 6393–6397.While certain regions of the BTV VP3 may tolerate
Marshall, J. J. A., and Roy, P. (1990). High level expression of the twosubstitutions or insertions of foreign sequences, the size
outer capsid proteins of bluetongue virus serotype 10: Their relation-of such insertions may prove limiting, depending on the
ship with the neutralisation of virus infection. Virus Res. 15, 189–
site. To date, the best candidate for insertion appears to 196.
be the carboxy terminus. Whether CLPs with the VP3 Oldfield, S., Adachi, A., Urakawa, T., Hirasawa, T., and Roy, P. (1990).
Purification and characterization of the major group-specific coremolecule carrying foreign immunogenic epitopes will be
antigen VP7 of bluetongue virus synthesized by a recombinant bacu-suitable for vaccine development is under investigation.
lovirus. J. Gen. Virol. 71, 2649–2656.
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